Evidence map›Paper›PMID 42080819›Full record

ArticleInorganic chemistry2026

Axial Chirality Induction in Ferrocene-Amino Acid Hybrids─toward Chiral Redox-Active Building Blocks.

Marcin Konopka, Rafał Śliwa, Marek P Szymański, Aleksandra Tobolska, Wojciech Wróblewski, Ireneusz Tomczyk, Katarzyna Rybicka-Jasińska, Artur Kasprzak, Agnieszka Szumna

Abstract read
In one paragraph

Article in Inorganic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marcin KonopkaInstitute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland.ORCID 0000-0002-6041-7655
Rafał ŚliwaFaculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland.ORCID 0009-0005-1588-1909
Marek P SzymańskiInstitute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland.ORCID 0000-0003-0916-1575
Aleksandra TobolskaFaculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland.ORCID 0000-0002-4643-7000
Wojciech WróblewskiFaculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland.ORCID 0000-0002-2806-4220
Ireneusz TomczykInstitute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland.ORCID 0000-0003-1018-1178
Katarzyna Rybicka-JasińskaInstitute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland.ORCID 0000-0002-9018-7846
Artur KasprzakFaculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664 Warsaw, Poland.ORCID 0000-0002-4895-1038
Agnieszka SzumnaInstitute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland.ORCID 0000-0003-3869-1321

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we report the construction of chiral ferrocene-containing (Fc) supramolecular platforms with high symmetry and well-defined geometry via dynamic covalent chemistry. Starting from amino acid hydrazides and ferrocene aldehydes, we obtained respective Fc-acylhydrazones with well-defined conformations, that display intense circular dichroism (CD) signals in the visible region associated with ferrocene-centered electronic transitions. CD and UV-vis spectroscopy, supported by computational analysis, reveal efficient transfer of chirality from the remote stereogenic centers to the Fc unit and a correlation between amino acid configuration, Fc helicity, and CD sign (l-amino acid → (

Identifiers

PMID42080819
PMCPMC13360310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.